INSR and Alzheimer disease: For example, in the (already brought up several times) authoritative review on the icv STZ model of AD, Salkovic-Petrisic et al. [56] opined that multiple parenteral treatment with low to moderate STZ doses causes insulin resistance by damaging insulin receptor (IR) signaling.